Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis

References

• Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol. 2019;7(X):1–11.
   PubMed Web of Science ®Google Scholar
• Violi F, Corazza GR, Caldwell SH, PRO-LIVER Collaborators, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian venous thrombotic events registry. Intern Emerg Med. 2016;11(8):1059–1066.
   PubMed Web of Science ®Google Scholar
• Qi X, Su C, Ren W, et al. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature. Clin Res Hepatol Gastroenterol. 2015;39(6):683–691.
   PubMed Web of Science ®Google Scholar
• Ghabril M, Agarwal S, Lacerda M, et al. Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: Analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients. Transplantation. 2016;100(1):126–133.
   PubMed Web of Science ®Google Scholar
• de Franchis R, Baveno VI Faculty Expanding consensus in portal hypertension: Report of the baveno VI consensus workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460.
   PubMed Web of Science ®Google Scholar
• Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;73(1):366–413.
   PubMed Web of Science ®Google Scholar
• Garcia-Pagan JC, Saffo S, Mandorfer M, et al. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep. 2020;2(4):100122.
   PubMedGoogle Scholar
• Qi X, He C, Guo W, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int. 2016;36(5):667–676.
   PubMed Web of Science ®Google Scholar
• Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis. 2021;2021:176–186.
   Google Scholar
• Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2014;18(4):853–876.
   PubMed Web of Science ®Google Scholar
• Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci. 2016;12(6):1381–1383.
   PubMed Web of Science ®Google Scholar
• Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol. 2016;28(7):739–743.
   PubMed Web of Science ®Google Scholar
• Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54(1):78–88.
   PubMed Web of Science ®Google Scholar
• de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – renewing consensus in portal hypertension. J Hepatol. 2021;76(4):959–974.
   PubMed Web of Science ®Google Scholar
• Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol. 2021;75(2):442–453.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wang MQ, Zhang GB, et al. Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt. WJH. 2016;8(20):850–857.
   PubMedGoogle Scholar
• Zhao D, Zhang G, Wang M, et al. Portal pressure gradient and serum albumin: a simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt. Clin Mol Hepatol. 2019;25(2):210–217.
   PubMed Web of Science ®Google Scholar
• Wang X, Mei X, Kong D. Effects of diabetes on the rebleeding rate following endoscopic treatment in patients with liver cirrhosis. Exp Ther Med. 2020;20(2):1299–1306.
   PubMed Web of Science ®Google Scholar
• Lv Y, Qi X, He C, PVT-TIPS Study Group., et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67(12):2156–2168.
   PubMed Web of Science ®Google Scholar
• Luca A, Miraglia R, Caruso S, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. GUT. 2011;60(6):846–852.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao H, Wang X, et al. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging. 2015;40(6):1813–1820.
   PubMedGoogle Scholar
• Luo X, Wang Z, Tsauo J, et al. Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. RADIOLOGY. 2015;276(1):286–293.
   PubMed Web of Science ®Google Scholar
• Holster IL, Tjwa ET, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding. Hepatology. 2016;63(2):581–589.
   PubMed Web of Science ®Google Scholar
• Schindler P, Heinzow H, Trebicka J, et al. Shunt-Induced hepatic encephalopathy in TIPS: Current approaches and clinical challenges. J Clin Med. 2020;9(11):3784.
   PubMed Web of Science ®Google Scholar
• Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology. 2014;60(2):715–735.
   PubMed Web of Science ®Google Scholar
• Lv Y, Yang Z, Liu L, AVB-TIPS Study Group, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587–598.
   PubMed Web of Science ®Google Scholar
• American Association for the Study of Liver Diseases, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European association for the study of the liver and the American association for the study of liver diseases. J Hepatol. 2014;61:642–659.
   PubMed Web of Science ®Google Scholar
• Thatcher BS, Sivak MJ, Ferguson DR, et al. Mesenteric venous thrombosis as a possible complication of endoscopic sclerotherapy: a report of two cases. Am J Gastroenterol. 1986;81(2):126–129.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu X, Hou Y, et al. Acute mesenteric vein thrombosis after endoscopic injection sclerotherapy for esophageal varices in a patient with liver cirrhosis. Drug Discov Ther. 2019;13(2):118–121.
   PubMed Web of Science ®Google Scholar
• Ashida H, Kotoura Y, Nishioka A, et al. Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy. Am J Gastroenterol. 1989;84(3):306–310.
   PubMed Web of Science ®Google Scholar
• Politoske D, Ralls P, Korula J. Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis. Dig Dis Sci. 1996;41(1):185–190.
   PubMed Web of Science ®Google Scholar
• Pettinari I, Vukotic R, Stefanescu H, BO-LIVES (Bologna LIVEr vascular Studies), et al. Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis. Am J Gastroenterol. 2019;114(2):258–266.
   PubMed Web of Science ®Google Scholar